Scarica l'app Stockscreener
3.33
5.67%
-0.20
Dopo l'orario di chiusura:
3.49
0.16
+4.80%
Mereo Biopharma Group Plc Adr Borsa (MREO) Ultime notizie
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Do investors need to be concerned about Mereo Biopharma Group Plc ADR (MREO)? - US Post News
Mereo Biopharma Group Plc ADR (MREO) gets rating Initiated from Robert W. Baird - Knox Daily
JP Morgan analysts upgrades an Overweight rating for Nucor Corp. (NUE) - Knox Daily
KeyBanc Capital Markets initates Alignment Healthcare Inc (ALHC) stock to a Sector weight - Knox Daily
Trading Day Review: Mereo Biopharma Group Plc ADR (MREO) Loses Momentum, Closing at 4.16 - The Dwinnex
Natera Inc (NTRA) receives a Buy rating from Jefferies - Knox Daily
Barclays initates Reinsurance Group Of America, Inc. (RGA) stock to an Overweight - Knox Daily
Recent Insider Activity Suggests Potential Gains for Mereo Biopharma Group Plc ADR (MREO) - Knox Daily
Potential Price Increase for Portland General Electric Co (POR) After Recent Insider Activity - Knox Daily
Analysts review KLA Corp.’s rating - Knox Daily
Perhaps timely catching Mereo Biopharma Group Plc ADR (MREO) would be a good idea - SETE News
MREO Stock Sees Surge of Approximately 7.32% in Last Five Days - Knox Daily
Stocks of Mereo Biopharma Group Plc ADR (MREO) are poised to climb above their peers - SETE News
Monitoring Mereo Biopharma Group Plc ADR (MREO) after recent insider movements - Knox Daily
Mereo Biopharma Group Plc ADR (MREO)’s stock price in review: A technical analysis - US Post News
Market Recap Check: Mereo Biopharma Group Plc ADR (MREO)’s Positive Finish at 4.14, Up/Down 0.98 - The Dwinnex
Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise By Investing.com - Investing.com South Africa
Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise - Investing.com
Mereo Biopharma Group Plc ADR [NASDAQ: MREO] Sees Increase in Stock Value - Knox Daily
A Look at Mereo Biopharma Group Plc ADR (MREO) Shares in the Recent Past Indicates Growth - SETE News
Examining Mereo Biopharma Group Plc ADR (MREO) more closely is necessary - US Post News
Xylem Inc [XYL] stock was sold by Harker Victoria D at the price of US$0.35 million - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
MULN’s latest rating updates from top analysts. - Knox Daily
Truist analysts initates a Hold rating for Expedia Group Inc (EXPE) - Knox Daily
Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex
Investing in Twist Bioscience Corp (TWST): What You Must Know - Knox Daily
OKX Ventures and Aptos Foundation Announce First Four Projects Selected for the Ankaa Accelerator Program - GlobeNewswire Inc.
Canopy Growth Corporation [CGC] Shares Fall -2.45 % on Wednesday - Knox Daily
Mereo Biopharma Group Plc ADR (MREO) stock: A year of ups and downs - US Post News
Mereo Biopharma Group Plc ADR (MREO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Mereo BioPharma CFO sells over $120k in company stock - Investing.com India
Mereo BioPharma CFO sells over $121k in company stock - Investing.com
Mereo BioPharma CEO sells over $381k in company stock - Investing.com
Mereo BioPharma's chief scientific officer sells shares worth over $69,000 - Investing.com India
Mereo BioPharma's general counsel sells over $133k in company stock - Investing.com India
Mereo BioPharma executive sells over $637k in company stock - Investing.com
Views of Wall Street’s Leading Experts on Mereo Biopharma Group Plc ADR - SETE News
Market Recap: Mereo Biopharma Group Plc ADR (MREO)’s Negative Momentum, Closing at 4.28 - The Dwinnex
The Potential Rise in the Price of Brixmor Property Group Inc (BRX) following insiders activity - Knox Daily
Taking a Closer Look At Replimune Group Inc (REPL) Following Its Recent Trade - Knox Daily
Mereo Biopharma Group Plc ADR (MREO) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Par Pacific Holdings Inc [PARR] stock for 224,940 USD was sold by Guerra Ivan Daniel - Knox Daily
Evolv Technologies Holdings Inc [EVLV] Shares Rise 1.03 % on Wednesday - Knox Daily
PDCO Shares Experience Surge in Value - Knox Daily
A year in review: Mereo Biopharma Group Plc ADR (MREO)’s performance in the last year - US Post News
Mereo Biopharma Group Plc ADR (MREO)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Mereo Biopharma Group Plc ADR (MREO) receives an Outperform rating from Robert W. Baird - Knox Daily
Monster Beverage Corp. [MNST] Insider Activity: An Update for Investors - Knox Daily
Healthy Upside Potential: Mereo Biopharma Group Plc ADR (MREO) - SETE News
Analyzing Ratios: Mereo Biopharma Group Plc ADR (MREO)’s Financial Story Unveiled - The Dwinnex
Mereo Biopharma Group Plc ADR [MREO] stock was sold by PAKIANATHAN DEEPIKA at the price of US$0.47 million - Knox Daily
Mereo Biopharma Group Plc ADR (MREO) did well last session? - US Post News
Gaining Ground: Mereo Biopharma Group Plc ADR (MREO) Closes Lower at 4.80, Down -1.44 - The Dwinnex
Mereo Biopharma Group Plc ADR (MREO) stock on the rise: An overview - US Post News
Get in on Mereo Biopharma Group Plc ADR’s (MREO) buy-in window today! - SETE News
Can Mereo Biopharma Group Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Mereo Biopharma Group Plc ADR’s Market Journey: Closing Weak at 4.44, Down -0.67 - The Dwinnex
Its Stock Has Paid Off Big Time For Mereo Biopharma Group Plc ADR - SETE News
MREO (Mereo Biopharma Group Plc ADR) may reap gains as insiders became active recently - Knoxdaily.com
Should investors be concerned about Mereo Biopharma Group Plc ADR (MREO)? - US Post News
Mereo BioPharma stock soars to 52-week high of $4.51 - Investing.com India
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
MREO’s Market Whiplash: 71.00% YTD Rise, -3.42% Plunge in 30 Days - The InvestChronicle
Mereo Biopharma Group Plc ADR (MREO)’s Day in Review: Closing at 3.76, Up by 1.08 - The Dwinnex
Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):